Lundbeck
HLUN-B.CO
#2596
Rank
$6.62 B
Marketcap
$6.98
Share price
0.63%
Change (1 day)
14.82%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): $0.85 Billion USD

According to Lundbeck's latest financial reports the company's current earnings are $3.61 Billion USD. In 2024 the company made an earning of $0.55 Billion USD, an increase over its 2023 earnings that were of $0.44 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $0.85 B54.23%
2024 $0.55 B25.74%
2023 $0.44 B21.77%
2022 $0.36 B31.57%
2021 $0.27 B-4.61%
2020 $0.28 B-45.06%
2019 $0.52 B-34.04%
2018 $0.79 B12.83%
2017 $0.70 B93.99%
2016 $0.36 B-137.28%
2015 -$0.98 Billion-1246.24%
2014 $85.02 M-72.36%
2013 $0.30 B4.38%
2012 $0.29 B-55.18%
2011 $0.65 B5.65%
2010 $0.62 B-5.9%
2009 $0.66 B